TrialAntimicrobial agents and chemotherapy2005

Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults.

Joseph D'Ignazio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.